NCT04308720View on ClinicalTrials.gov

Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 20, 2028

Study Completion Date

October 20, 2028

Conditions
Breast Cancer
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04308720 - Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer | Biotech Hunter | Biotech Hunter